Raymond T. Johnson

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy.

Chris Gregory, Bin He, Raymond T. Johnson et al. · PubMed · 2001 · 608 citations

Androgen Receptor, Urology, Genitourinary Cancer +12

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

Christopher W. Gregory, Raymond T. Johnson, James L. Mohler et al. · PubMed · 2001 · 500 citations

Androgen Receptor, Low Androgen, Androgen Receptor Stabilization +17

Androgen Receptor Regulation of G1 Cyclin and Cyclin‐Dependent Kinase Function in the CWR22 Human Prostate Cancer Xenograft

Christopher W. Gregory, Raymond T. Johnson, Sharon C. Presnell et al. · Journal of Andrology · 2001 · 68 citations · Full text

Urology, G Protein-coupled Receptor, Hormonal Receptor +15

2-(Arylmethyl)-3-substituted quinuclidines as selective α7 nicotinic receptor ligands

Anatoly Mazurov, Jozef Klucik, Lan Miao et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 27 citations · Full text

Pharmacology, Molecular Pharmacology, Medicine +1

Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?

Michael F. Sarosdy, Paul F. Schellhammer, Raymond T. Johnson et al. · Urology · 2000 · 19 citations

Hormonal Contraceptive, Medicine, Pharmacology +7